The Role of Acute-Phase Reactant Proteins, Carcinoembryonic Antigen and CA 19-9 as a Marker in the Preoperative Staging of Colorectal Cancer: A Prospective Clinical Study

International Surgery

Volumn 81, Issue 2, 1996, Pages 136-139

  Yüceyar, Serdar ^a,b   Ertürk, Süphan ^a   Dirican, Ahmet ^a   Cengiz, Ali ^a   Saner, Haluk ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Ug̃ur Apt ^*  (Turkey)

Author keywords

Acute phase reactant protein; Alpha 1 acide glycoprotein; Alpha 1 antitrypsin; C reactive protein; Carbonhydrate antigen 19 9 (CA 19 9); Carcinoembryonic antigen; Colorectal neoplasms

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTITRYPSIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; OROSOMUCOID; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MULTIVARIATE ANALYSIS; PREOPERATIVE EVALUATION; PROGNOSIS; REGRESSION ANALYSIS;

ACUTE-PHASE PROTEINS; ADENOCARCINOMA; ADULT; AGED; ALPHA 1-ANTITRYPSIN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OROSOMUCOID; TUMOR MARKERS, BIOLOGICAL;

EID: 0029950394     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Schwartz MK. Cancer Markers. In: De Vita V T, Hellman S Jr, Rosenberg S A, editors. Cancer Principles and Practice of oncology. 4th edition. Philadelphia: JB Lippincott Company, 1993;1:531-542.
2. Walker C, Gray BN. Acute-Phase Reactant Proteins and Carcinoembryonic Antigen in Cancer of the Colon and Rectum. Cancer 1983;52:150-154.
3. Bernacka K, Kuryliszyn-Moskal A, Sierakowski S. The levels of Alpha1-Antitrypsin and Alpha1-Antichymotrypsin in the Sera of Patients with Gastrointestinal Cancers during Diagnosis. Cancer 1988;62:1188-1193.
4. Cohen AM, Minsky BD, Schilsky RL. Colon Cancer. In: De Vita VT, Hellman S Jr Rosenberg SA, editors. Cancer principles and practice of Oncology. 4th edition Philadelphia: JB Lippincott Company, 1993; 1:929-973.
5. McCall JL, Black RB, Rich CA et al. The Value of Serum Carcinoembryonic antigen in Predicting Recurrent Disease following Curative Resection of Colorectal Cancer. Dis Colon Rectum 1994;37:875-881.
6. Wang JY, Tang R, Chiang Jy M. Values of Carcinoembryonic Antigen in the Management of Colorectal Cancer. Dis Colon Rectum 1994;37:272-277.
7. Hohenberger P, Schlag PM, Gerneth T, Herfarth C. Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Ann Surg 1994;219:135-143.
8. Bruinvels DJ, Stiggelbout AM, Kievit J et al. Follow-up of Patients with Colorectal Cancer: A Meta-Analysis. Ann Surg 1994;219:174-182.
9. Durdey P, Williams NS, Brown DA. Serum carcinoembryonic antigen and acute phase reactant proteins in the preoperative detection of fixation of colorectal tumours. Br J Surg 1984; 71:881-884.
10. Dinarello CA, Wolff SM: Pathogenesis of fever and the acute phase response. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of Infectious Diseases. 4th edition. New York: Churchill Livingstone, 1995;1:530-536.
11. Krecicki T, Leluk M. Acute phase reactant proteins: An aid to monitoring surgical treatment of laryngeal carcinoma. J Laryngol Otol 1992;106:613-615.
12. Stamatiadis AP, Toumanidou M St, Vyssoulis GP, Manouras AJ, Apostolidis NS. Values of Serum Acute-phase Reactant Proteins and Carcinoembryonic antigen in the Preoperative Staging of Colorectal Cancer. Cancer 1990;65:2055-2057.
13. Putzki H, Hafner O. Sensitivitat und spezifitat von Alpha-1-Antitrypsin und saurem Alpha-1-Glykoprotein beim Kolorektalen Karzinom. Gastroenterol J 1991;51:104-107.
14. Stamatiadis AP, Manouras AJ, Triantos GN, Katergiannakis VA, Apostolidis NS. Combination of serum carcinoembryonic antigen and C-Reactive protein: a useful test in preoperative staging of colorectal cancer. Eur J Surg Oncol 1992;18:41-43.
15. Kodner IJ, Fry RD, Fleshman JW, Birnbaum EH. Colon, Rectum and Anus. In: Schwartz SI, editor. Principles of Surgery. 6th edition New York: McGraw- Hill, 1994;2:1191-1306.
16. Dawson-Saunders B, Trapp RG. Basic and clinical Biostatistics. 1st edition. USA, Appleton - Lange, 1990.
17. Dinçol K. Onkoloji. In: Büyüköztürk K, editor. "Iç Hastaliklan" birinci baski, cilt-1. Istanbul: Nobel Tip Kitabevi, 1992;Suppl: 77, 104.
18. Ueda T, Shimada E, Urakawa T. The clinical pathologic features of serum CA 19-9 positive colorectal cancers. Surg Today 1994;24:518-525.
19. Tramont EC, Hoover DL. General or nonspecific host defense mechanism. In: Mandell GL, Bennett JE, Dolin R, (editors). Principles of Infectious Diseases. 4th edition. New York: Churchill Livingstone, 1995:30-35.
20. Locksley RM, Wilson CB. Cell-mediated immunity and its role in host defense. In: Mandell GL, Bennett JE, Dolin R, editors. Principles of Infectious Diseases. 4th edition. New York: Churchill Livingstone, 1995;1:102-149.
21. Durdey P, Cooper JC, King RFGJ, Williams NS. The role of peptidases in cancer of rectum and sigmoid colon. Br J Surg 1985;72: 378-381.
22. Broom J, Heys SD, Whiting PH. Interleukin-2 therapy in cancer: identification of responders. Br J Cancer 1992;66:1185-1187.